Xcout Intel
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Grand Rapids, Michigan, focused on developing innovative therapies for metabolic and liver diseases.
Subscribe to see Cirius Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cirius Therapeutics, Inc. at a glance
Cirius Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $89.6M across the 7 funding rounds on record. Its most recent funding round raised $800,000 in October 2025. Xcout tracks 14 named people at Cirius Therapeutics, Inc., including Robert A Beardsley (Chief Executive Officer).
Cirius Therapeutics, Inc. leadership
- Robert A BeardsleyChief Executive Officer
- Jerry ColcaChief Science Officer
- Jerry A CallahanExecutive Officer
- Jerry CallahanExecutive Officer
- Mark OlesnavageExecutive Officer
- Robert A BeardsleyExecutive Officer
8 more named people on record for Cirius Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Cirius Therapeutics, Inc. funding rounds
At least $89.6M raised across the 7 rounds on record. The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $800,000 | — | |
| SEC Form D filing | $1M | — | |
| SEC Form D filing | $1.3M | — | |
| SEC Form D filing | $7.5M | — | |
| SEC Form D filing | $9M | — | |
| SEC Form D filing | $30M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Cirius Therapeutics, Inc. competitors
A few of Cirius Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Akero Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company is dedicated to developing transformational therapies for metabolic dysfunction-associated steatohepatitis and other metabolic diseases.
Tetra Discovery Partners is a biopharmaceutical company headquartered in Grand Rapids, Michigan, with a business office in Cambridge, Massachusetts.
Syntis Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to revolutionizing oral therapies for obesity and metabolic diseases.
Iterion Therapeutics is a clinical-stage biopharmaceutical company headquartered in Houston, Texas. Founded in 2015, the company is dedicated to revolutionizing healthcare through novel drug discovery and innovation.
Centaurus Therapeutics is a clinical-stage biotechnology company that develops first-in-class small-molecule therapies targeting ceramides to treat cardio-kidney-metabolic (CKM) diseases. The company's lead oral asset, CNT2130, inhibits DES1 to reduce excess ceramide production and restore lipid balance for patients suffering from organ decline.
MDI Therapeutics, Inc. is a pharmaceutical company headquartered in Novi, Michigan. The company specializes in researching and developing novel therapeutics for the treatment of fibrosis and related fibrotic diseases.
Get Cirius Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cirius Therapeutics, Inc. in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access